Edition:
United States

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

10.50USD
8 Dec 2017
Change (% chg)

$-0.01 (-0.10%)
Prev Close
$10.51
Open
$10.45
Day's High
$11.00
Day's Low
$10.45
Volume
18,504
Avg. Vol
--
52-wk High
$15.39
52-wk Low
$9.94

Revenue & Earnings Per Share

 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 4 0.15 0.20 0.00 --
Quarter Ending Mar-18 1 0.00 0.00 0.00 --
Year Ending Dec-17 4 0.66 0.79 0.39 --
Year Ending Dec-18 4 5.00 10.80 0.00 --
Earnings (per share)
Quarter Ending Dec-17 4 -1.23 -0.79 -1.97 --
Quarter Ending Mar-18 2 -1.59 -0.91 -2.26 --
Year Ending Dec-17 4 -6.32 -3.01 -11.09 --
Year Ending Dec-18 4 -5.14 -3.06 -9.48 --
LT Growth Rate (%) 1 0.60 0.60 0.60 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 186.11 35.51
P/E High - Last 5 Yrs. -- 274.30 45.27
P/E Low - Last 5 Yrs. -- 92.17 24.24
Beta -- 0.83 0.91
Price to Sales (TTM) 194.30 113.99 5.83
Price to Book (MRQ) -- 21.50 5.68
Price to Tangible Book (MRQ) 4.43 25.23 7.26
Price to Cash Flow (TTM) -- 101.64 24.44
% Owned Institutions 0.32 5.68 1.39

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.96 5.23
Payout Ratio(TTM) -- 95.86 45.95

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -2.88 6.82
Sales (TTM) vs TTM 1 Yr. Ago -- 30.21 5.65
Sales - 5 Yr. Growth Rate -- 33.15 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -35.71 -147.47 7.23
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 43.45 10.90
Capital Spending - 5 Yr. Growth Rate -- 40.96 15.17

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.79 2.54
Current Ratio (MRQ) 5.85 5.75 3.56
LT Debt to Equity (MRQ) 0.00 14.45 13.23
Total Debt to Equity (MRQ) 0.00 16.90 19.24
Interest Coverage (TTM) -- -147.16 44.55

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.05 54.80
Gross Margin - 5 Yr. Avg. -- 55.37 52.40
EBITD Margin (TTM) -4,711.05 -- --
EBITD - 5 Yr. Avg -- -219.17 15.52
Operating Margin (TTM) -4,763.54 -631.99 6.76
Operating Margin - 5 Yr. Avg. -- -236.03 11.03
Pre-Tax Margin (TTM) -4,459.81 -602.68 7.58
Pre-Tax Margin - 5 Yr. Avg. -- -236.35 11.44
Net Profit Margin (TTM) -4,459.81 -600.25 3.81
Net Profit Margin - 5 Yr. Avg. -- -239.62 7.73
Effective Tax Rate (TTM) -- 15.32 24.25
Effective Tax Rate - 5 Yr. Avg. -- 18.76 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 24,966 21,633,432 858,823,705
Net Income/Employee (TTM) -1,113,414 -1,703,997 100,224,560
Receivable Turnover (TTM) -- 25.40 6.12
Inventory Turnover (TTM) -- 2.62 3.55
Asset Turnover (TTM) -- 0.42 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -9.13 11.35
Return on Assets - 5 Yr. Avg. -- 0.30 12.32
Return on Investment (TTM) -- -11.32 14.47
Return on Investment - 5 Yr. Avg. -- 3.50 16.13
Return on Equity (TTM) -- -35.69 16.06
Return on Equity - 5 Yr. Avg. -- 5.92 17.32
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -122.89 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Spero Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -25.80 -27.73 8 96
13 Week -- -- -- 71
26 Week -- -- -- 64
52 Week -- -- -- 62
YTD -- -- -- 49
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 8.00%
# of Holders: 2
Total Shares Held: 1,071,966
3 Mo. Net Change: 1,071,966
# New Positions: 2
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 0
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.